Bio-Thera Solutions Ltd. has entered a partnership with the biotechnology company BeiGene for licensing, distribution and supply of its investigational biosimilar(bevacizumab) candidate, BAT1706, in China.
The collaboration was announced shortly after China’s regulatory authority, National Medical Products Administration, approved the biologics license application for BAT1706.






